Drug Profile
Ascorbyl gamolenate
Alternative Names: Ascorbyl-gamma-linolenic acid; Ascorbyl-GLA; SC 103aLatest Information Update: 22 Jan 2002
Price :
$50
*
At a glance
- Originator Scotia Holdings [CEASED]
- Class
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic neuropathies
Most Recent Events
- 22 Jan 2002 Discontinued-I for Diabetic neuropathies in United Kingdom (PO)
- 19 Nov 1999 Phase-I clinical trials for Diabetic neuropathies in United Kingdom (PO)
- 20 May 1999 SC 103 is now called Ascorbyl gamolenate